Abstract
Bone metastases are one of the most common complications of cancer. Up to 70% of patients with advanced breast cancer metastasize to the bone. The standard long-term treatment of bone metastases is bisphosphonates. This effective therapy, however, is able to cause serious side effects. Osteonecrosis of the jaw (ONJ) is a recently detected adverse outcome associated in rare cases with bisphosphonate therapy.
| Titel in Übersetzung | Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care |
|---|---|
| Originalsprache | Deutsch |
| Seiten (von - bis) | 702-706 |
| Seitenumfang | 5 |
| Fachzeitschrift | Wiener Medizinische Wochenschrift |
| Jahrgang | 158 |
| Ausgabenummer | 23-24 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 2008 |
| Extern publiziert | Ja |
Schlagwörter
- Bone Density Conservation Agents/adverse effects
- Bone Neoplasms/secondary
- Breast Neoplasms/therapy
- Carcinoma, Ductal/secondary
- Combined Modality Therapy
- Diphosphonates/adverse effects
- Disease Progression
- Female
- Humans
- Image Processing, Computer-Assisted
- Imaging, Three-Dimensional
- Mandibular Diseases/chemically induced
- Maxillary Diseases/chemically induced
- Middle Aged
- Neoplasm Recurrence, Local/therapy
- Osteonecrosis/chemically induced
- Tomography, X-Ray Computed
- Osteonecrosis of the jaw
- Bisphosphonates
- Bone metastasis
ASJC Scopus Sachgebiete
- Allgemeine Medizin